請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/7070
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 潘文涵(Wen-Harn Pan) | |
dc.contributor.author | Chien-Hui Tsai | en |
dc.contributor.author | 蔡健慧 | zh_TW |
dc.date.accessioned | 2021-05-17T10:18:10Z | - |
dc.date.available | 2012-06-01 | |
dc.date.available | 2021-05-17T10:18:10Z | - |
dc.date.copyright | 2012-01-17 | |
dc.date.issued | 2011 | |
dc.date.submitted | 2011-10-18 | |
dc.identifier.citation | 1 Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289: 2560–72.
2 Chobanian AV, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42(6): 1206-52. 3 Lawes CM, Bennett DA, Lewington S, Rodgers A. Blood pressure and coronary heart disease: a review of the evidence. Semin Vasc Med. 2002; 2(4): 355-68. 4 Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365: 217–23. 5 Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM. 2006. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006; 47: 296–308. 6 Savica V, Bellinghieri G, Kopple JD. The effect of nutrition on blood pressure. Annu Rev Nutr. 2010; 30: 365-401. 7 Armstrong B, van Merwyk AJ, Coates H. Blood pressure in Seventh-day Adventist vegetarians. Am J Epidemiol. 1977; 105: 444-449. 8 He J, Klag MJ, Whelton PK, Chen JY, Qian MC, He GQ. Dietary macronutrients and blood pressure in southwestern China. Journal of hypertension. 1995; 13: 1267–1274. 9 Umesawa M, Sato S, Imano H, Kitamura A, Shimamoto T, et al. Relations between protein intake and blood pressure in Japanese men and women: the Circulatory Risk in Communities Study (CIRCS). The American journal of clinical nutrition. 2009; 90: 377–384. 10 Stamler J, Elliott P, Kesteloot H, et al; INTERSALT Cooperative Research Group. Inverse relation of dietary protein markers with blood pressure: findings for 10,020 men and women in the INTERSALT study. Circulation. 1996; 94: 1629-1634. 11 Elliott P et al. Association between protein intake and blood pressure: the INTERMAP Study. Arch Intern Med. 2006; 166(1): 79-87. 12 Alonso A, Beunza JJ, Bes-Rastrollo M, Pajares RM, Martinez-Gonzalez MA Vegetable protein and fiber from cereal are inversely associated with the risk of hypertension in a Spanish cohort. Archives of medical research. 2006; 37: 778–786. 13 Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, Miller ER III. et al. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids. Results of the OmniHeart Randomized Trial. JAMA. 2005; 294: 2455–64. 14 Altorf-van der Kuil W et al. Dietary protein and blood pressure: a systematic review. PLoS One. 2010; 5(8): e12102. 15 Appel LJ et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997; 336(16): 1117-24. 16 Rivellese AA, Maffetone A, Vessby B, et al. Effects of dietary saturated, monounsaturated and n_3 fatty acids on fasting lipoproteins, LDL size and postprandial lipid metabolism in healthy subjects. Atherosclerosis. 2003; 167: 149–58. 17 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285(19): 2486-97. 18 Ascherio A, et al. A prospective study of nutritional factors and hypertension among US men. Circulation. 1992; 86(5): 1475-84. 19 Rasmussen BM, et al. Effects of dietary saturated, monounsaturated, and n-3 fatty acids on blood pressure in healthy subjects. Am J Clin Nutr. 2006; 83(2): 221-6. 20 Martinez-Gonzalez MA, Sanchez-Villegas A. The emerging role of Mediterranean diets in cardiovascular epidemiology: monounsaturated fats, olive oil, red wine or the whole pattern? European Journal of Epidemiology. 2004; 19: 9–13. 21 Psaltopoulou T, Naska A, Orfanos P, Trichopoulos D, Mountokalakis T, Trichopoulou A. Olive oil, the Mediterranean diet, and arterial blood pressure: the Greek European Prospective Investigation into Cancer and Nutrition (EPIC) study. American Journal of Clinical Nutrition. 2004; 80: 1012–8. 22 Trevisan M, Krogh V, Freudenheim J, Blake A, Muti P, Panico S, et al. Consumption of olive oil, butter, and vegetable oils and coronary heart disease risk factors. The Research Group ATS-RF2 of the Italian National Research Council. Journal of the American Medical Association. 1990; 263: 688–92. 23 Alonso A, Martinez-Gonzalez MA. Olive oil consumption and reduced incidence of hypertension: the SUN Study. Lipids. 2004; 39: 1233–8. 24 Ferrara LA, Raimondi AS, d’Episcopo L, Guida L, Dello Russo A, Marotta T. Olive oil and reduced need for antihypertensive medications. Archives of Internal Medicine. 2000; 160: 837–42. 25 Perona JS, Canizares J, Montero E, Sanchez-Dominguez JM, Catala A, Ruiz-Gutierrez V. Virgin olive oil reduces blood pressure in hypertensive elderly subjects. Clinical Nutrition. 2004; 23: 1113–21. 26 Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation. 1993; 88: 523–533. 27 Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ. Blood pressure response to fish oil supplementation: meta-regression analysis of randomized trials. J Hypertension. 2002; 20: 1493–1499. 28 Hartweg J et al. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes. Diabetologia. 2007; 50(2): 250-8. 29 Elliot P. Observational studies of salt and blood pressure. Hypertension. 1991; 17(suppl.): I3–8 30 The INTERSALT Study: background, methods, findings, and implications. Am J Clin Nutr. 1997; 65(suppl.): 626S–42S. 31 Sacks FM, Svetkey LP, Vollmer WM, et al, for the DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med. 2001; 344: 3–10. 32 Welton PK, Appel LJ, Espeland MA, et al, for the TONE Collaborative Research Group. Sodium reduction and weight loss in the treatment of hypertension in older persons. JAMA. 1998; 279: 839–46. 33 He FJ, MacGregor GA. Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet. 2011; 378: 380-2. 34 He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertension. 2002; 16(11): 761-70. 35 Stamler J, Rose G, Eliot P, Dyer A, Marmot M, Kesteloot H, and Stamler R. Findings of the international cooperative INTERSALT study. Hypertension. 1991; 17 Suppl 1: 9–15. 36 Krishna GG, Miller E, and Kapoor S. Increased blood pressure during potassium depletion in normotensive men. N Engl J Med. 1989; 320: 1177–1182. 37 Buemi M, Senatore M, Corica F, Aloisi C, Romeo A, Tramontana D, et al. Diet and arterial hypertension: Is the sodium ion alone important? Medical Research Reviews. 2002; 22(4): 419–428. 38 Barri YM et al. The effects of potassium depletion and supplementation on blood pressure: a clinical review. Am J Med Sci. 1997; 314(1): 37-40. 39 Sarkkinen ES. et al. Feasibility and antihypertensive effect of replacing regular salt with mineral salt -rich in magnesium and potassium- in subjects with mildly elevated blood pressure. Nutr J. 2011; 10: 88. 40 Capuccio FP and MacGregor GA. Does potassium supplementation lower blood pressure? A meta analysis of published trials. Hypertension. 1991; 9: 465–473. 41 Dickinson HO, Nicolson DJ, Campbell F, Beyer FR, Mason J. Potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev. 2006; 3: CD004641. 42 Tobian L. Salt and hypertension. Hypertension 1992; 17 Suppl 1: 52–58. 43 Cappuccio FP, Elliott P, Allender PS, Pryer J, Follman DA, Cutler JA. Epidemiologic association between dietary calcium intake and blood pressure: a meta-analysis of published data. Am J Epidemiol. 1995; 142(9): 935-45. 44 Cappuccio FP, Siani A, Strazzullo P. Oral calcium supplementation and blood pressure: an overview of randomized controlled trials. J Hypertens. 1989; 7(12): 941-6. 45 Bucher HC, Cook RJ, Guyatt GH, Lang JD, Cook DJ, Hatala R, Hunt DL. Effects of dietary calcium supplementation on blood pressure. A meta-analysis of randomized controlled trials. JAMA. 1996; 275(13): 1016-22. 46 Griffith LE, Guyatt GH, Cook RJ, Bucher HC, Cook DJ. The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials. Am J Hypertension. 1999; 12: 84-92. 47 Dickinson HO, Nicolson DJ, Cook JV, Campbell F, Beyer FR, Ford GA, Mason J. Calcium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev. 2006; (2): CD004639. 48 Burgess E, Lewanczuk R, Bolli P, Chockalingam A, Cutler H, Taylor G, Hamet P. Recommendations on potassium, magnesium and calcium. Canadian Medical Association Journal. 1999; 160 (Suppl 9): 35S–45S. 49 Jee SH, Miller III ER, Guallar E, Singh VK, Appel LJ, Klag MJ. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized controlled trials. American Journal of Hypertension. 2002; 15(8): 691–696. 50 Dickinson HO, Nicolson DJ, Campbell F, Cook JV, Beyer FR, Ford GA, Mason J. Magnesium supplementation for the management of essential hypertension in adults. Cochrane Database Syst Rev. 2006; 3: CD004640. 51 Ascherio A, Stampfer MJ, Colditz GA, Willett WC, McKinlay J. Nutrient intakes and blood pressure in normotensive males. Int J Epidemiol. 1991; 20: 886–891. 52 Witteman JCM, Willett WC, Stampfer MJ, Colditz GA, Sacks FM, Speizer FE, et al. A prospective study of nutritional factors and hypertension among US women. Circulation. 1989; 80: 1320–1327. 53 Swain JF, Rouse IL, Curley CB, Sacks FM. Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure. N Engl J Med. 1990; 322: 147–152. 54 Eliasson K, Ryttig KR, Hylander B, Rossner S. A dietary fibre supplement in the treatment of mild hypertension. A randomized, double-blind, placebo-controlled trial. J Hypertension. 1992; 10: 195–199. 55 Whelton SP, Hyre AD, Pedersen B, Yi Y, Whelton PK, He J. Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J Hypertension. 2005; 23(3): 475-81. 56 American Diabetes Association. Standards of medical care in diabetes--2010. Diabetes Care. 2010; 33 Suppl 1: S11-61. 57 Chang HY et al. Gender differences in trends in diabetes prevalence from 1993 to 2008 in Taiwan. Diabetes Res Clin Pract. 2010; 90(3): 358-64. 58 Yeh CJ, Chang HY, Pan WH. Time trend of obesity, the metabolic syndrome and related dietary pattern in Taiwan: from NAHSIT 1993-1996 to NAHSIT 2005-2008. Asia Pac J Clin Nutr. 2011; 20(2): 292-300. 59 Thanopoulou AC et al. Dietary fat intake as risk factor for the development of diabetes: multinational, multicenter study of the Mediterranean Group for the Study of Diabetes (MGSD). Diabetes Care. 2003; 26(2): 302-7. 60 Laaksonen DE, Lakka TA, Lakka HM, Nyyssonen K, Rissanen T, Niskanen LK, Salonen JT. Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabetes Med. 2002; 19(6): 456-64. 61 Tanasescu M, Cho E, Manson JE, Hu FB. Dietary fat and cholesterol and the risk of cardiovascular disease among women with type 2 diabetes. Am J Clin Nutr. 2004; 79(6): 999-1005. 62 Mayer EJ, Newman B, Quesenberry Jr CP, Selby JV. Usual dietary fat intake and insulin concentrations in healthy women twins. Diabetes Care. 1993; 16: 1459–69. 63 Feskens EJ, Loeber JG, Kromhout D. Diet and physical activity as determinants of hyperinsulinemia: the Zutphen elderly study. Am J Epidemiol. 1994; 140: 350–60. 64 Marshall JA, Bessesen DH, Hamman RF. High saturated fat and low starch and fibre are associated with hyperinsulinemia in non diabetic population: the San Luis Valley diabetes study. Diabetologia. 1997; 40: 430–8. 65 Vessby B et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia. 2001; 44(3): 312-9. 66 Mayer-Davis EJ, Monaco JH, Hoen HM, et al. Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The insulin resistance atherosclerosis study (IRAS). Am J Clin Nutr. 1997; 65: 79–89. 67 Lovejoy JC et al. Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. Diabetes Care. 2002; 25(8): 1283-8. 68 Paniagua JA et al. A MUFA-rich diet improves posprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects. J Am Coll Nutr. 2007; 26(5): 434-44. 69 Akinkuolie AO, Ngwa JS, Meigs JB, Djousse L. Omega-3 polyunsaturated fatty acid and insulin sensitivity: A meta-analysis of randomized controlled trials. Clin Nutr. 2011 Sep 28. [Epub ahead of print] 70 Hartweg J, Perera R, Montori V, Dinneen S, Neil HA, Farmer A. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2008; (1): CD003205. 71 Griffin MD et al. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: the OPTILIP Study. Am J Clin Nutr. 2006; 84(6): 1290-8. 72 Belin RJ, He K: Magnesium physiology and pathogenic mechanisms that contribute to the development of the metabolic syndrome. Magnes Res. 2007; 20: 107–129. 73 Kim DJ, Xun P, Liu K, Loria C, Yokota K, Jacobs DR Jr, He K. Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care. 2010; 33(12): 2604-10. 74 Lopez-Ridaura R, Willett WC, Rimm EB, Liu S, Stampfer MJ, Manson JE, Hu FB: Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care. 2004; 27: 134–140. 75 Meyer KA, Kushi LH, Jacobs DR Jr., Slavin J, Sellers TA, Folsom AR: Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr. 2000; 71: 921–930. 76 Kao WH et al. Serum and Dietary Magnesium and the Risk for Type 2 Diabetes Mellitus. Arch Intern Med. 1999; 159: 2151-2159. 77 Fung TT, Manson JE, Solomon CG, Liu S, Willett WC, Hu FB. The association between magnesium intake and fasting insulin concentration in healthy middle-aged women. J Am Coll Nutr. 2003; 22(6): 533-8. 78 Paolisso G et al. Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr. 1992; 55(6): 1161-7. 79 Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care. 2003; 26(4): 1147-52. 80 Ludwig DS et al. Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA. 1999; 282(16): 1539-46. 81 Schulze MB et al. Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women. Am J Clin Nutr. 2004; 80(2): 348-56. 82 Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ, Hoogwerf BJ, Lichtenstein AH, Mayer-Davis E, Mooradian AD, Wheeler ML : Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008; 31( Suppl. 1): S61– S78 83 Brand-Miller J, Hayne S, Petocz P, Colagiuri S. Low-glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled trials. Diabetes Care. 2003; 26(8): 2261–2267. 84 Jenkins DJ et al. Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial. JAMA. 2008; 300(23): 2742-53. 85 Ford ES, Liu S. Glycemic index and serum high-density lipoprotein cholesterol concentration among us adults. Arch Intern Med. 2001; 161(4): 572–576. 86 Salmeron J, Ascherio A, Rimm EB, et al. Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care. 1997; 20(4): 545–550. 87 Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA. 1997; 277(6): 472–477. 88 Liu S, Willett WC, Stampfer MJ, et al. A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr. 2000; 71(6): 1455–1461. 89 Barclay AW et al. Glycemic index, glycemic load, and chronic disease risk--a meta-analysis of observational studies. Am J Clin Nutr. 2008; 87(3): 627-37. 90 Dyer RG, Stewart MW, Metcheson J, George K, Alberti MM, Laker MF, et al. 7-ketocholesterol, a specific indicator of lipoprotein oxidation and malondialdehyde in non-insulin dependent diabetes and peripheral vascular disease. Clin Chim Acta. 1997; 260: 1-13. 91 Evans M, Anderson RA, Smith JC, Khan N, Graham JM, Thomas AW, et al. Effects of insulin lispro and chronic vitamin C therapy on postprandial lipaemia, oxidative stress and endothelial function in patients with type 2 diabetes mellitus. Eur J Clin Invest. 2003; 33: 231-8. 92 Errikson J, Kahvakka A. Magnesium and ascorbic acid supplementation in diabetes mellitus. Ann Nutr Metab. 1995; 39: 217-23. 93 Afkhami-Ardekani M, Shojaoddiny-Ardekani A. Effect of vitamin C on blood glucose, serum lipids & serum insulin in type 2 diabetes patients. Indian J Med Res. 2007; 126(5): 471-4. 94 Sargeant LA, Wareham NJ, Bingham Luben RN, Oakes S, Welch A, et al. Vitamin C and hyperglycemia in the European prospective investigation into cancer- Norfolk (EPIC-Norfolk) study. Diabetes Care. 2000; 23: 726-32. 95 Lu-Chen Weng, Wen-Harn Pan et al. A counting system for potassium-containing foods and its application for increasing dietary potassium intake. Nutritional Sciences Journal. Vol.31 No.4 December 2006. 96 Ni-Jen Lee, Wen-Harn Pan et al. A counting system for magnesium-rich foods. Nutritional Sciences Journal. Vol.30 No.2 September 2005. 97台灣行政院衛生署「國人膳食營養素參考攝取量及其說明 修訂第六版」 98 Obarzanek E, et al. Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr. 2001; 74(1): 80-9. 99 Meena S, Beverley Adams-Huet, and Abhimanyu Garg. Effect of high-carbohydrate or high-cis-monounsaturated fat diets on blood pressure: a meta-analysis of intervention trials. Am J Clin Nutr. 2007; 85: 1251– 6. 100 Alonso A, Ruiz-Gutierrez V, Martinez-Gonzalez MA. Monounsaturated fatty acids, olive oil and blood pressure: epidemiological, clinical and experimental evidence. Public Health Nutr. 2006; 9(2): 251-7. 101 Ellie Whitney et al. Understanding Nutrition 10TH Edition. 102 Devaraj S, Jialal I. The role of dietary supplementation with plant sterols and stanols in the prevention of cardiovascular disease. Nutr Rev. 2006; 64(7 Pt 1): 348-54. 103 D'Evoli L et al. Influence of rosemary (Rosmarinus officinalis, L.) on plant sterol oxidation in extra virgin olive oil. Mol Nutr Food Res. 2006; 50(9): 818-23. 104 Vlahakis C and Hazebroek J. Phytosterol accumulation in canola, sunflower, and soybean oils: Effects of genetics, planting location, and temperature. JAOCS. 2000; 77(1): 49-53. 105 Spyros A, Dais P. Application of (31)P NMR spectroscopy in food analysis. 1. Quantitative determination of the mono- and diglyceride composition of olive oils. J Agric Food Chem. 2000; 48(3): 802-5. 106 Chung TY, Nwokolo EN, Sim JS. Compositional and digestibility changes in sprouted barley and canola seeds. Plant Foods Hum Nutr. 1989; 39(3): 267-78. 107 Al-Solaiman Y et al. DASH Lowers Blood Pressure in Obese Hypertensives Beyond Potassium, Magnesium and Fiber. J Hum Hypertens. 2010; 24(4): 237–246. 108 Kodama S et al. Influence of fat and carbohydrate proportions on the metabolic profile in patients with type 2 diabetes: a meta-analysis. Diabetes Care. 2009; 32(5): 959-65. 109 Knowler WC et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346(6): 393-403. 110 Ronald P Mensink, Peter L Zock, Arnold DM Kester, and Martijn B Katan. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003; 77: 1146–55. 111 Stamler J, Liu K, Ruth KJ, Pryer J, Greenland P. Eight-year blood pressure change in middle-aged men: relationship to multiple nutrients. Hypertension. 2002; 39(5): 1000-6. 112 Wang YF, Yancy WS Jr, Yu D, Champagne C, Appel LJ, Lin PH. The relationship between dietary protein intake and blood pressure: results from the PREMIER study. J Human Hypertension. 2008; 22(11): 745-54. 113 Papakonstantinou E et al. A high-protein low-fat diet is more effective in improving blood pressure and triglycerides in calorie-restricted obese individuals with newly diagnosed type 2 diabetes. Eur J Clin Nutr. 2010; 64(6): 595-602. 114 Delbridge EA, Prendergast LA, Pritchard JE, Proietto J. One-year weight maintenance after significant weight loss in healthy overweight and obese subjects: does diet composition matter? Am J Clin Nutr. 2009; 90(5): 1203-14. 115 De Natale C et al. Effects of a plant-based high-carbohydrate/high-fiber diet versus high-monounsaturated fat/low-carbohydrate diet on postprandial lipids in type 2 diabetic patients. Diabetes Care. 2009; 32(12): 2168-73. 116 Giacco R et al. Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids? Nutr Metab Cardiovasc Dis. 2007; 17(8): 572-80. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/7070 | - |
dc.description.abstract | 研究背景與目的:
高血壓與糖尿病是重要的公共衛生議題。過去有許多研究顯示飲食療法能除去對高血壓或糖尿病藥物的依賴,減少醫療花費,並且除了改善目標疾病,還有其他附加價值,像是預防其他慢性疾病之發生及改善生活品質,因此,從改變生活飲食型態的層面來改善國人血壓及血糖狀況為當務之急。過去在美國臨床試驗顯示得舒飲食可有效幫助高血壓患者降低血壓。得舒飲食是一種富含鉀、鎂、鈣、纖維與較少飽和脂肪酸、較少膽固醇的飲食,以西式菜餚所設計的飲食。本研究想證實以華人飲食設計的得舒飲食是否同樣有降血壓的效果,並進一步評估維持得舒飲食鉀、鎂、鈣、纖維含量與飽和脂肪酸的比例,但減少得舒飲食醣類比例的減醣得舒飲食是否對於降低血壓、血糖和血脂有更好的效果。 材料與方法: 本研究為一個隨機交叉的飲食性介入試驗。共有36位年齡為20~65歲,符合收縮壓130~159mmHg或舒張壓85~99mmHg或血糖100~125mg/dl其中一項條件,且簽署同意書願意參加試驗的受試者。本研究將受試者隨機分配成二組,分別隨機先後給予得舒飲食和減醣得舒飲食。減醣得舒飲食與得舒飲食的不同在於減少得舒飲食的醣類比例,其減少的部份以使用豆製品和芥花油的方式,由蛋白質、單元不飽和脂肪酸各一部份取代。試驗方式為給予受試者食用4個星期的第一種飲食後,緊接著4個星期的沖淡期,再進行4星期的第二種飲食,試驗前後共計12個星期。在受試者食用試驗飲食前與試驗期間,研究人院定期測量受試者的血壓、血糖和血脂值,並且定期收集受試者的尿液以檢測尿液中的電解質。 研究結果: 得舒飲食的組別其與基線相比之收縮壓、舒張壓和血糖值分別下降7.91mmHg、4.64mmHg和3.53mg/dl (P<0.05)。減醣得舒飲食的組別其與基線相比之收縮壓、舒張壓和血糖值分別下降5.13mmHg、2.63mmHg和3.69mg/dl (P<0.05)。兩種飲食的血壓及血糖下降效果沒有顯著差異,但對於血壓偏高的受試者,得舒飲食收縮壓下降的效果較減糖得舒飲食好,且有顯著差異(P=0.04)。在血脂方面,兩種飲食對總膽固醇和LDL-C都有顯著的下降效果。減醣得舒飲食對於禁食胰島素濃度、三酸甘油酯有顯著下降效果,對於HDL-C/TC比例有顯著上升的效果。 結論: 台灣化得舒飲食和得舒減醣飲食都能有效降低血壓,在血壓偏高的族群中,血壓下降的程度較血壓正常者大,並且台灣化得舒飲食對收縮壓下降較減醣得舒飲食有更好的效果。減醣得舒飲能同時改善血壓、血糖和三酸甘油酯。 | zh_TW |
dc.description.abstract | Background & objective:
Hypertension and diabetes are important public health problems in Taiwan and in the world. Many studies have shown that dietary therapy can ease high blood pressure or diabetes drug dependence and reduce medical costs. In addition, dietary therapy can prevent other chronic diseases and improve total wellbeing. Therefore, it is imperative to promote dietary and lifestyle therapy for newly diagnosed patients. Clinical trials have shown that the US. DASH diet can effectively help lower blood pressure in patients with hypertension. The DASH diet is rich in potassium, magnesium, calcium, fiber and low in saturated fatty acids, low cholesterol content. This study is firstly to confirm whether a Chinese-style DASH diet has not only a similar blood pressure lowering effect, but also effects on blood glucose and lipids. Secondly, assessment was made to see whether a reduced carbohydrate DASH diet can lower blood pressure, blood glucose and blood lipids. This diet has similar levels of potassium, magnesium, calcium, fiber and percentage of saturated fatty acids, but reduced proportion of carbohydrate. Method: This study adopted a randomized crossover dietary intervention trial. Thirty six participants were in the trial. They were aged 20 to 65, with systolic blood pressure 130 ~ 159mmHg or diastolic blood pressure 85 ~ 99mmHg or fasting blood glucose 100 ~ 125mg/dl. Participants were randomly assigned to two groups, each was given either DASH diet or reduced carbohydrate DASH diet in different stage. Soybean products and canola oil were used to increase the proportion of protein and monounsaturated fatty acid and thus reduce the carbohydrate in reduced carbohydrate DASH. Participants consumed the first diet for 4 weeks, followed by four weeks of washout period, then the second diet for 4 weeks. Total experiment lasted 12 weeks. Before and during the experiment, participants were regularly measured for blood pressure, blood glucose and lipid values. Urine was regularly collected to monitor urinary electrolytes. Result: In DASH diet group, systolic blood pressure, diastolic blood pressure and blood glucose levels decreased 7.91mmHg, 4.64mmHg and 3.53mg/dl, respectively (P <0.05). Where as in the reduced carbohydrate DASH diet group, they decreased 5.13mmHg, 2.63mmHg and 3.69mg/dl respectively (P <0.05). However, there were no significant differences between two kinds of diets in blood pressure and blood glucose lowering effect. Only in those with pre-hypertension and hypertension, the DASH diet (-8.85mmHg) group decreased mean systolic blood pressure more so than the reduced carbohydrate DASH diet (-5.06mmHg) group (P = 0.04). And for lipids, both diets significantly decreased total cholesterol and LDL-C. Reduced carbohydrate DASH diet group significantly decreased fasting insulin, triglycerides and significantly increased HDL-C/TC ratio. Conclusion: Chinese-style DASH diet and reduced carbohydrate DASH diet can effectively lower blood pressure. In high blood pressure participants, both diet lower blood pressure effectively, and DASH diet has better effect than reduced carbohydrate DASH diet. In addition to lowering the blood pressure, reduced carbohydrate DASH can also lower insulin and triglycerides, and increase HDL/TC ratio. | en |
dc.description.provenance | Made available in DSpace on 2021-05-17T10:18:10Z (GMT). No. of bitstreams: 1 ntu-100-R98b47306-1.pdf: 2179040 bytes, checksum: 64eb83f44d179614b97f1fdab6fb05ae (MD5) Previous issue date: 2011 | en |
dc.description.tableofcontents | 中文摘要……………………………………………………………………………… i
英文摘要……………………………………………………………………………...iii 縮寫對照表……………………………………………………………………………v 目錄…………………………………….....……………………………………………I 圖目錄……………………………………………………………………………….…Ⅲ 表目錄………………………………………………………………………………….Ⅳ 第一章 研究背景………………………………………………………………………1 第一節 前言……………………………………………………………………………1 第二節 高血壓之定義與台灣現況……………………………………………………2 第三節 血壓與飲食因子:回顧觀察性研究與臨床試驗結果…………………………3 第四節 血壓相關飲食介入臨床試驗…………………………………………………7 第五節 糖尿病之定義與台灣現況…………………………………………………14 第六節 血糖與飲食因子:回顧觀察性研究與臨床試驗結果………………………15 第二章 材料與方法…………………………………………………………………19 第一節 研究設計……………………………………………………………………19 第二節 受試者資格…………………………………………………………………19 第三節 招募與篩選…………………………………………………………………20 第四節 分層隨機分派………………………………………………………………24 第五節 飲食型態與菜單……………………………………………………………24 第六節 受試者飲食規範……………………………………………………………31 第七節 問卷項目……………………………………………………………………31 第八節 資料收集……………………………………………………………………32 第九節 統計分析……………………………………………………………………33 第三章 結果…………………………………………………………………………35 第一節 設計飲食與實際飲食和菜單………………………………………………35 第二節 個案基線資料………………………………………………………………35 第三節 血壓…………………………………………………………………………37 第四節 禁食血糖和胰島素…………………………………………………………40 第五節 血脂…………………………………………………………………………41 第六節 尿液…………………………………………………………………………42 第四章 討論…………………………………………………………………………43 第一節 主要結果…………………………………………………………………….43 第二節 研究設計…………………………………………………………………….43 第三節 得舒飲食效果………………………………………………………………44 第四節 減醣得舒飲食效果…………………………………………………………45 第五節 比較得舒飲食和減醣得舒飲食.……………………………………………47 第六節 研究限制.……………………………………………………………………49 第五章 結論與未來展望……………………………………………………………50 參考文獻 ………………………………………………………………………………90 附錄.……………………………………………………………………………………99 附錄一:同意書.……………………………………………………………………100 附錄二:電子傳單……………………………………………………………………106 附錄三:便當展示活動傳單與海報…………………………………………………107 附錄四:血壓測量標準流程…………………………………………………………108 附錄五:鉀點數表、鎂點數表………………………………………………………111 附錄六:基本資料表…………………………………………………………………116 附錄七:抽菸喝酒頻率問卷…………………………………………………………117 附錄八:飲食頻率問卷………………………………………………………………119 附錄九:抽血標準流程………………………………………………………………133 附錄十:收集尿意標準流程…………………………………………………………137 附錄十一:測量前叮嚀………………………………………………………………139 附錄十二:體檢流程…………………………………………………………………140 | |
dc.language.iso | zh-TW | |
dc.title | 設計適合「高血壓前期或第一期、糖尿病前期患者」的「降血壓、降血糖」飲食及其效果評估 | zh_TW |
dc.title | Designing and testing efficacy of blood pressure and glucose lowering diets for Taiwanese patients with pre-/1st staged hypertension and/or pre-diabetes | en |
dc.type | Thesis | |
dc.date.schoolyear | 100-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 張新儀(Hsing-Yi Chang),黃孟娟(Meng-Chuan Huang) | |
dc.subject.keyword | 得舒飲食,減醣得舒飲食,血壓,血糖, | zh_TW |
dc.subject.keyword | DASH,reduced carbohydrate DASH,blood pressure,blood glucose, | en |
dc.relation.page | 140 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2011-10-19 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 生化科技學系 | zh_TW |
顯示於系所單位: | 生化科技學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-100-1.pdf | 2.13 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。